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Abstract Cone arrestin (CAR) is a novel member of the arrest-
in superfamily expressed in retinal cone photoreceptors and the
pineal gland. To understand the regulatory mechanisms control-
ling its cone- and pineal-speci¢c expression, and to facilitate
further functional studies using gene knockout approaches, we
characterized the genomic organization and the 5P-£anking re-
gion of the mouse CAR (mCAR) gene. The mCAR gene is
comprised of 17 exons and 16 introns, encoding ¢ve alterna-
tively spliced transcripts. A 215-bp proximal promoter fragment
containing a TATA box, an Sp1 site and four cone-rod homeo-
box-binding sites is su⁄cient to direct expression in cultured
retinoblastoma cells and in cone photoreceptors and the pineal
gland in transgenic Xenopus laevis. + 2002 Published by El-
sevier Science B.V. on behalf of the Federation of European
Biochemical Societies.
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1. Introduction
Arrestins comprise a superfamily of regulatory proteins that
bind to activated, phosphorylated G-protein-coupled recep-
tors (GPCRs), leading to uncoupling from G-proteins in a
process termed desensitization [1,2]. The arrestin superfamily
includes visual arrestins, L-arrestins and insect chemosensory
arrestins. Two members of the visual arrestins have been iden-
ti¢ed in vertebrate photoreceptors: rod arrestin (also known
as S-antigen or arrestin 1) and cone arrestin (CAR, X-arrestin
or arrestin 4).
Rod arrestin was the ¢rst member in the arrestin superfam-
ily to be molecularly characterized [3], and its function has
been extensively studied in recent years. In vertebrate rod
photoreceptors, rod arrestin quenches the light-induced pho-
totransduction cascade by binding to light-activated, phos-
phorylated rhodopsin [4,5]. Recently, arrestin has been found
to participate in a molecular pathway for light-induced photo-
receptor apoptosis in Drosophila through the formation of
stable rhodopsin^arrestin complexes that are recruited to the
cytoplasmic compartment through clathrin-dependent endocy-
tosis [6^8].
Unlike visual arrestins, L-arrestin 1 and L-arrestin 2 have a
ubiquitous expression pattern [9,10]. Although L-arrestins
have a similar function to rod arrestin in the termination
of GPCR signaling [9,10], recent evidence indicates that
they have additional roles in signaling to downstream
e¡ectors [11,12] because of their ability to act as adap-
tors to facilitate clathrin-mediated endocytosis [13,14]. L-Ar-
restins also recruit activated tyrosine kinase c-Src into com-
plexes with the L2 adrenergic receptor, which is involved
in the activation of extracellular signal-regulated kinases
(ERK1 and ERK2), one of three groups of mitogen-acti-
vated protein kinases (MAPKs) [15^17]. Recently, L-arrestin
2 has been identi¢ed as a binding partner of c-Jun amino-
terminal kinase 3 (JNK3) and was suggested to act as a
receptor-regulated MAPK sca¡old for the activation of
JNK3 [18].
CAR was ¢rst cloned from a rat pineal library and was
discovered to be highly expressed in retina and pineal gland
[19]. Based on this observation, a human retina cDNA
(hCAR) was identi¢ed, its mRNA was localized in cone pho-
toreceptors and a subset of pinealocytes, and the gene was
mapped to the X chromosome [19,20]. Subsequently, numer-
ous CAR orthologs have been cloned from other vertebrates,
including clawed frog [21], killi¢sh [22], bullfrog [23], leopard
frog [23], bovine [24] and salamander [25]. Its high sequence
homology to other arrestins and its cone photoreceptor local-
ization suggest that CAR may play as important a role in the
modulation of phototransduction in cones as rod arrestin does
in rods; however, its actual function is still unknown
[19,21,26].
To facilitate the functional studies of CAR using transgenic
and gene knockout technologies, and to delineate the reg-
ulatory mechanisms controlling cone photoreceptor- and
pineal-speci¢c expression, we isolated and characterized
the mouse CAR (mCAR) cDNA and gene, as well as its
5P regulatory region. We show that a 215-bp fragment con-
taining the proximal promoter drives reporter expression to
cone photoreceptors and the pineal gland in transgenic
Xenopus.
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2. Materials and methods
2.1. cDNA library screen
An mCAR cDNA fragment of 550 bp was ampli¢ed by reverse
transcriptase-polymerase chain reaction (RT-PCR) from mouse
retinal total RNA using the published protocol [27] with the following
primers designed based on the human CAR (hCAR) cDNA sequence
(GenBank accession number U03626) [19] : +hCAR (171^194): 5P-
TCGCTATGGCCGTGATGACTTGGA-3P, 3hCAR (743^720): 5P-
TTGGTGTACTTGTCTAGTGAATAC-3P.
The fragment was labeled with [K-32P]dCTP and was used as a
probe to screen a VZAP mouse eye cDNA library (gift from Hans-
Jurgen Fulle, USC and David Garber, UT Southwestern Med. Ctr.)
as previously described [28]. After three sequential rounds of plaque
screening, the ¢nal isolates were excised and the isolated cDNAs were
sequenced on both strands by automatic sequence analysis using the
ABI Genetic Analyzer Model 310 (Perkin Elmer, Foster City, CA,
USA) [29].
2.2. Determination of intron/exon junctions of the mCAR gene
A mouse ES 129/Svj BAC genomic library was screened with an
mCAR cDNA probe by Genome Systems, Inc., according to their
standard protocol. Southern blot analyses with a 5P probe (the short
promoter fragment p-215) and a 3P probe (the cDNA fragment from
the anchor to the stop codon) were used to map the positive clones.
One clone (mCAR BAC16505) was identi¢ed to contain both the
5P-£anking region and the 3P end of the cDNA and was used as a
template in the PCR reactions to amplify overlapping genomic frag-
ments for sequence analysis. Primers were designed according to the
mCAR cDNA sequence to amplify overlapping genomic fragments
with the high ¢delity Turbo DNA polymerase (Stratagene). The am-
pli¢ed fragments were cloned into the pCR-Blunt II-TOPO vector
(Invitrogen) and sequenced on both strands. Comparison of the ge-
nomic sequence and the cDNA sequence was used to con¢rm the
identity of the clones and to ascertain intron/exon boundaries.
2.3. RT-PCR
To isolate the full-length mCAR cDNA without unspliced introns,
a primer was designed at the predicted translation start codon ATG
of the cDNA clones (5P-ATG/TCC/ACA/GTG/TTT/AAG/AAG-3P)
and was paired with an antisense primer from the 3P non-coding
region of the rat pineal CAR (rpCAR) sequence (5P-GCT/TCC/
ACA/CAG/AAT/TAT/CAG/AGA-3P) [19] for RT-PCR. RT-PCR
was performed with 1 Wg of mouse retinal total RNA as previously
described [27]. The RT-PCR products were cloned into the PCR 2.1
vector (Invitrogen, Carlsbad, CA, USA) and sequenced on both
strands.
2.4. 3P-Rapid ampli¢cation of cDNA ends (3P-RACE)
3P-RACE was performed using a 3P-RACE kit (Life Technologies,
Gaithersburg, MD, USA) following the manufacturer’s instructions.
Mouse retinal cDNA was synthesized from 1 Wg of total RNA using
the adapter primer provided in the kit. The abridged universal ampli-
¢cation primer (AUAP) from the kit was paired with the arrestin
anchor primer, +rpARR (878^898) (5P- CTC/AAG/CAT/GAA/
GAC/ACA/AAT-3P) (amino acid: LKHEDTN) [19] to amplify a frag-
ment that contained sequences from the conserved arrestin signature
domain [19] to the poly(A) tail. The RACE products were cloned into
the PCR2.1 vector (Invitrogen) and sequenced on both strands.
2.5. Isolation of the 5P-£anking region of the mCAR gene
To clone the promoter region of the mCAR gene, the Mouse Ge-
nomeWalker kit (Clontech, Palo Alto, CA, USA) was used according
to the manufacturer’s instructions. An mCAR gene-speci¢c primer 1
(5P-AAAGGAGGTGGACTTAGTATGGGC-3P), which was derived
from the ¢rst intron of the gene located within the 5P untranslated
region of the mCAR cDNA, was used in primary PCR using the ¢ve
di¡erent mouse genomic libraries supplied by the kit as templates.
Undiluted primary PCR products (1 Wl) were used as templates for
secondary PCR using an mCAR gene-speci¢c primer 2 (5P-GAGG-
GAAGAGATGAAGCTCACATCAG-3P), derived from the 5P un-
translated region upstream of the ¢rst intron. The secondary PCR
products were cloned into the pGlow-TOPO TA cloning vector (In-
vitrogen) and sequenced on both strands. The sequences were ana-
lyzed using on-line Promoter Scan II (Prestridge, 1995), Signal Scan
(Prestridge, 1991), and TFSEARCH programs.
2.6. 5P-RACE
The transcription start sites of the mCAR gene were identi¢ed by
5P-RACE using the SMART RACE cDNA Ampli¢cation kit (Clon-
tech) according to the manufacturer’s instructions. Brie£y, ¢rst-strand
cDNA was synthesized from mouse retina and cerebellum poly(A)þ
RNA. An mCAR gene-speci¢c primer (3mCAR (462^442), 5P-TTC-
CTGAATCTTCAGGCCCAG-3P), derived from the mCAR cDNA
sequence, and the universal primer mix from the kit were used in
primary PCR using 2.5 Wl of diluted cDNA as template. Gel analysis
of 10 Wl of primary PCR products revealed a smear. A secondary
PCR was performed using a nested mCAR gene-speci¢c primer
(3mCAR (391^367), 5P-GGATAGGCATTGACCCCGAGCTTG-
3P), and the nested universal primer from the kit with 2.5 Wl of 1:50
diluted primary PCR products as template. The PCR products were
cloned into the TOPO TA cloning vector (Invitrogen) and sequenced
on both strands.
2.7. Primer extension
Primer extension reactions were carried out using the primer exten-
sion system (Promega, Madison, WI, USA) with 10 Wg of total RNA
and 0.1 pmol of Q-32P end-labeled primer (3mCAR (36^15), 5P-CCC-
ATTGGAGCTAGTCTTCTTA-3P) that is complementary to the se-
quence of nucleotides 15^36 relative to the translation start site, fol-
lowing the manufacturer’s instructions. Half of the extended products
were resolved on 8% denaturing polyacrylamide gels and exposed to a
Phosphorimager screen (Molecular Dynamics).
2.8. Analysis of mCAR promoter^reporter constructs in cell culture
The p-215, p-523 and p-1003 mCAR 5P-£anking fragments in the
pGlow-TOPO vector in the sense orientation were digested with SpeI
and PstI, subcloned into the pRL-null vector through its SpeI and
PstI sites, and analyzed for promoter activity.
Cell culture and transient transfection of Weri-Rb-1 retinoblastoma
and COS-7 cells were performed as described previously [30]. Weri-
Rb-1 and COS-7 cells grown in six-well plates were transiently trans-
fected with 1.6 Wg of mCAR promoter^luciferase reporter construct or
the promoterless pRL-null vector, and 0.4 Wg of the pGL3-C plasmid
as an internal control of the transfection e⁄ciency. For cone-rod
homeobox (CRX) co-transfection, 1 Wg of the CRX mammalian ex-
pression construct in the pcDNA3 vector was used with 0.8 Wg of
mCAR promoter^luciferase reporter construct and 0.2 Wg of the
pGL3-C plasmid. After 44 h, cells were harvested and assayed for
luciferase activity [30]. Renilla luciferase activity was normalized to
the ¢re£y luciferase activity of the same sample and expressed as fold
of the promoterless control.
2.9. Production of transgenic Xenopus laevis
The p-215, p-523 and p-1003 mCAR promoter fragments in the
pRL-null vector were digested with HindIII and PstI and subcloned
into the pEGFP1 reporter vector (Clontech) through its HindIII and
PstI sites. Transgenic X. laevis embryos were produced as described
[31]. The numbers of green £uorescent protein (GFP)-positive em-
bryos out of the total that survived beyond 2 weeks were 19 of 40
for the p-1003 construct, eight of 21 for the p-523 construct and 11 of
28 for the p-215 construct. Tadpoles were photographed on a dissect-
ing microscope equipped with £uorescence module (MZFl111, Leica,
Inc.) and an RT Slider Spot CCD camera (Diagnostic Instruments,
Inc.). Low power images were collected with both bright ¢eld and
£uorescent illumination. GFP-positive transgenic tadpoles (stages
50^56) were ¢xed overnight in 4% paraformaldehyde in phosphate
bu¡er and transferred to 20% (w/v) sucrose in phosphate bu¡er. Fro-
zen sections of 10^15 Wm thickness were prepared, and £uorescent
images were obtained as described [32]. Figures were prepared with
Adobe Photoshop.
3. Results and discussion
3.1. Gene structure and alternative splicing of mCAR
An adult mouse eye cDNA library was screened using an
mCAR PCR fragment as a probe. Of 1U106 recombinants
screened, four positive clones (411A, 422B, 511B and 1013B)
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were obtained after the tertiary screen. Sequence analysis re-
vealed that all four cDNA clones contained only partial cod-
ing regions with unspliced introns at various positions com-
pared to the human gene [33], indicating incomplete splicing
of the mRNA and a complex gene structure. The longest
clone, 1013B, was 2.3 kb in length with a 5P non-coding region
of 48 bp, and its 3P end was within intron 12. Clone 422B had
an in-frame splicing out of exon 4.
The mCAR gene structure was determined by characteriz-
ing a BAC genomic clone containing the complete mCAR
gene (mCAR BAC16505) isolated from a mouse ES cell li-
brary by Southern blot analysis (data not shown) and by
sequencing overlapping gene fragments ampli¢ed with pairs
of exon primers. A total of 17 exons and 16 introns were
identi¢ed, spanning approximately 13 kb of genomic DNA
(Fig. 1A). Exon sizes range from 10 to 315 bp, and intron
sizes range from 104 to 4381 bp (Table 1). Both the organi-
zation and the exon/intron boundary sequences of the mCAR
gene are in good agreement with those of the hCAR gene [33],
and the splice junctions conform to the donor/acceptor con-
sensus sequences [34] (Table 1). The whole gene sequence
matches a contig (accession number AC091784) in the Gen-
Bank database except for a few nucleotides.
To isolate the complete coding region of mCAR, a sense
primer containing the predicted ¢rst ATG and an antisense
primer in the 3P non-coding region were used for RT-PCR.
Also, the 3P non-coding sequence of mCAR was identi¢ed by
3P-RACE using the kit provided primer and the arrestin an-
chor primer [19] to amplify a fragment that contained mCAR
cDNA sequence from the conserved arrestin signature domain
to the poly(A) tail. The ampli¢ed products were cloned and
sequenced. The sequences from 5P-RACE, RT-PCR and 3P-
RACE were then assembled to generate the mCAR cDNAs
with 5P and 3P non-coding regions. To our surprise, ¢ve di¡er-
ent forms of cDNA were identi¢ed (Fig. 1B). The dominant
species among the various isoforms corresponded to CARs
from other species and was named mCAR full-length
(mCARFL) (GenBank accession number AF156979). Clone
12 has an alternate exon 17 (E17b) that is produced by the
use of a di¡erent splice acceptor in intron 16, which is 151 bp
upstream of the splice acceptor for the original exon 17
(E17a). The existence of an in-frame stop codon in the 151-
bp additional sequences in clone 12 results in a predicted
protein with a di¡erent C-terminus than the other mCAR
isoforms. The other three isoforms of mCAR each have
an in-frame splicing out of one or two exons in exon 4
(mCARvE4), 14 (mCARvE14) or 13 and 14 (mCARvE13
and 14). These results indicate that the primary mCAR tran-
script is processed into several mRNA variants, the major one
being the mCARFL.
Alternative splicing is a common feature for the arrestin
gene family [35^38], and for many other photoreceptor-specif-
Fig. 1. Structure of the mCAR gene and its cDNA isoforms. The exon numbers are indicated. Filled and shaded boxes represent the coding se-
quence. A: Exon/intron organization of the mCAR gene. B: cDNA isoforms of mCAR obtained from an eye library screen, RT-PCR, 5P- and
3P-RACE of mouse retinal RNA. The length of the polypeptide and the predicted molecular weight for each isoform are given.
Table 1
Exon/intron organization of the mCAR gene
Exon numbera Exon size (bp) Intron size (kb) Splice acceptor Splice donor
1a 39 1.016 CTTCCCTCAGgtaatattct
1b 89 1.016 CTTCCCTCAGgtaatattct
2 28 0.239 ctcatctcagGAAAGATTCA GCATGTCCACgtaagaatcc
3 31 0.150 caccccacagAGTGTTTAAG CAATGGGAAGgtaagagaac
4 61 0.197 tccacaacagTTTTCCATCT GAGCCCATTGgttagtgagt
5 45 4.381 ctctctgcagATGGAGTCGT GGTCGAAAGTgtaagtagaa
6 200 0.104 ttgccagcagTGTTTGTCAG TACACTTCAGgtactgacct
7 60 0.677 gatttcctagATGGTTGCTA TTCAGGAAAGgtaaggaaga
8 68 0.636 ttttttatagCCCTGTGGGG TCCCTAAGAGgtagtctttg
9 136 0.195 ctttactcagTGATTCTGTG GGACAGGGAGgttggtagca
10 85 0.216 cctgcttcagGTTCATTACC AAGATTGCAGgtaagcttct
11 73 0.398 actttttcagTTGTCCAGAC AGGAGTTCACgtgagctggg
12 138 2.160 tctttcaaagAGAGACAGTA CTAGCACAATgtaagctcat
13 84 0.247 taatgtcaagTCTTCGACCT CCTATGGGGGgtaagtgagg
14 24 0.171 ttattcacagCATTCTAGGA TGCCAGCCAGgtgagaagct
15 65 0.229 atgcttgcagTGATGTTGGT GAGAGAGCAGgtgaggctac
16 10 0.601 cttgccacagTGGCTACCAG TGGCTACCAGgtaagtcagc
17a 164 ctcctgaaagCTCGGAGGAC
17b 315 cattatctagACAGATTCCG
aExon numbering is according to Fig. 1.
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ic genes [27,39^42]. It has been suggested that P44, the trun-
cated form of bovine rod arrestin lacking the C-terminus gen-
erated by splicing out exon 16 of the bovine rod arrestin gene,
is the major form to bind phosphorylated, activated rhodop-
sin in vivo [43]. The mRNA for the human splice variant of
rod arrestin, which is present at approximately 1/20 the level
of the human rod arrestin mRNA, was produced by splicing
out exon 12 of the human gene [38]. The splice variant lacking
E14 (8 aa) has been reported both in L-arrestin 1 [35] and
L-arrestin 2 [36].
Although di¡erent splice variants have been reported for
both rod arrestin and L-arrestins in various species, this is
the ¢rst report of alternative splicing of the CAR gene. More-
over, isoforms lacking E4 (vE4), lacking E13^14 (vE13 and
14), and having an alternate E17 (clone 12), have not been
reported for any members of the arrestin family. Ongoing
experiments are being directed to determine the relative
amount and the functional signi¢cance of each alternatively
spliced form.
3.2. Structural analysis of the mCAR 5P-£anking region
A 5P-RACE was performed to characterize the transcription
start site of the mCAR mRNA. After the second round of
ampli¢cation, the RACE products from the retinal RNA
turned out to be a doublet of V500 bp on an ethidium bro-
mide-stained agarose gel, but no ampli¢ed products were ob-
tained from the cerebellum RNA (data not shown), con¢rm-
ing the retina-enriched expression, and suggesting two
potential transcription start sites of mCAR. The RACE prod-
ucts were cloned into the pCRII-TOPO cloning vector, and
31 clones were randomly picked for sequence analysis. The
majority of the clones (19 out of 31) started 59 bp upstream
of the predicted translation start codon, 11 bp longer at the
5P end than the cDNA from library screening (1013B). This
transcription start site is con¢rmed to be the major transcrip-
tion start site by primer extension (see below) and is desig-
nated +1 (Fig. 3). The remaining clones (12 out of 31) started
50 bp further upstream, and the location is marked MTS as
minor transcription start site (Fig. 3). Interestingly, none of
the clones that had the additional 50-bp 5P non-coding region
had exon 4, while all the clones that started from the major
transcription start site had exon 4, suggesting that the cDNA
isoform of mCARvE4 is the one that has a longer 5P non-
coding region because of the use of the MTS (Fig. 1B). A
PCR analysis was performed with a sense primer within the
additional 50-bp 5P non-coding region and an antisense prim-
er within exon 4 using the 5P-RACE cDNA as template. As
expected, no speci¢c products were ampli¢ed. However, a
speci¢c band was ampli¢ed when a sense primer in the
5P non-coding region downstream of the major transcription
site was used.
To con¢rm the transcription start sites, we performed prim-
er extension with an antisense primer in the third exon, which
is complementary to 74^95 of the cDNA sequence relative to
the major transcription start site decided by 5P-RACE. As
shown in Fig. 2, two extended bands were obtained from
the retinal RNA but not from the cerebellum RNA, with
the major extended product being 95 bp and the minor one
being 145 bp, exactly matching the 5P-RACE results. The
major extended product was about 10 times more intense
than the minor one, suggesting that the major transcription
start site is used 10 times more. We did not see this di¡erence
Fig. 2. Primer extension of total RNA (10 Wg) from light-adapted
mouse retina (lane 1), dark-adapted mouse retina (lane 2), and
mouse cerebellum (lane 3). The extended products are identi¢ed
with arrows, and the sizes of the extended products are indicated.
M, [Q-32P]ATP end-labeled PX174 HinfI DNA size markers. The
length in bp for each DNA HinfI fragment in the marker lane is in-
dicated next to the corresponding band.
Fig. 3. Sequence analysis of the mCAR 5P-£anking region. The nucleotide sequence of the mCAR 5P-£anking fragments is shown with the po-
tential transcriptional regulatory elements identi¢ed by sequence comparisons. The major transcription start site is indicated +1, and the minor
one is marked MTS. The ¢rst base of the mCAR cDNA identi¢ed by retinal cDNA library screening is marked cDNA. The TATA box and
the TATA-like element are boxed. Other promoter elements and their direction are also indicated.
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with the 5P-RACE experiment because 5P-RACE was a PCR-
based experiment that was not quantitative since we ampli¢ed
for 30 cycles, which was already beyond the linear phase of
the PCR reaction. No signi¢cant di¡erence was seen in RNA
from retinas between day (light) and night (dark) (Fig. 2),
suggesting that mCAR mRNA expression may not be regu-
lated by light exposure as in the case for rod arrestin [44,45].
To amplify the 5P-£anking region of mCAR, nested gene-
speci¢c antisense primers were designed according to the se-
quences of intron 1 and exon 1 for use with the Genome-
Walker kit as described in Section 2, resulting in the gener-
ation of three overlapping PCR fragments of 215, 523 and
1003 bp. Analysis of the 1003-bp fragment, p-1003, with on-
line promoter analysis programs, identi¢ed numerous poten-
tial cis-elements (Fig. 3). The proximal promoter region is
highly conserved between hCAR [33] and mCAR, both carry-
ing a TATA box, a TATA-like element and at least three
potential binding sites for CRX, a retinal/pineal-speci¢c tran-
scription factor [46^49]. The second transcription start site
(MTS) of mCAR, which is 50 bp upstream of the major
one, is probably due to the use of the upstream TATA-like
element at position 3119 (Fig. 3), 63 bp upstream of the
MTS. Although this TATA-like element is conserved between
mouse and human, it is unclear if a second transcription start
site is also present in the human gene.
3.3. Promoter activity of the mCAR 5P-£anking region
To delineate the sequences that drive photoreceptor-speci¢c
expression of mCAR, the p-215, p-523 and p-1003 5P-£anking
fragments in the pGlow-TOPO vector were subcloned into the
Renilla luciferase reporter vector pRL-null. As shown in Fig.
4, each of these promoter constructs was able to drive lucif-
erase expression in Weri-Rb-1 retinoblastoma cells, which
have been shown to express CRX at a high level [30,50],
but none of them was able to drive reporter expression in
COS-7 cells. Co-transfection of a CRX expression construct
with the promoter^reporter constructs in COS-7 cells reveals
luciferase expression (Fig. 4), suggesting that CRX is partially
responsible for retina-speci¢c expression of mCAR. CRX-
binding sites have been localized to the promoter regions of
many retina-enriched genes, including rhodopsin, rod arrestin
and interphotoreceptor retinoid-binding protein (IRBP) [32,
33,46,50,51]. Thus, the cone photoreceptor-speci¢c expression
of CAR must involve other transcription factors in addition
to CRX. The p-523 fragment has the strongest promoter ac-
tivity in Weri-Rb-1 cells, indicating the existence of negative
regulating elements in the p-1003 fragment. Interestingly, all
three fragments show comparable promoter activities in CRX-
co-transfected COS-7 cells, con¢rming that other transcription
factors in Weri-Rb-1 cells participate in regulating the pro-
moter activities through binding sites located upstream of the
p-215 fragment.
3.4. mCAR 5P-£anking sequence directs expression in cone
photoreceptors and the pineal gland in transgenic X. laevis
The cone-speci¢c expression of color opsins [52], cone
transducin K subunit [53], and cone cGMP-phosphodiesterase
[54,55] has been found to be tightly regulated. A conserved
sequence was reported in the locus control region, upstream
of the red and green opsin genes, that is required for cone
photoreceptor-speci¢c expression in transgenic mice [56]. Fur-
ther functional analysis of the human red and green opsin
gene promoters revealed that the cell-speci¢c expression of
these genes is controlled mainly by positive-acting elements
in the proximal region between 3130 and the TATA box
[57]. Transgenic studies show that a 277-bp 5P-£anking frag-
ment from the human cone transducin K subunit gene coupled
with a 214-bp IRBP enhancer can direct cone-speci¢c expres-
sion of the reporter gene in mouse retina [58]. In our studies,
we show that the proximal promoter region of the mCAR
gene has high sequence homology with that of its human
counterpart, suggesting that the elements controlling the
cone-speci¢c expression of CAR are most likely within this
region.
To elucidate this hypothesis, we developed transgenic Xen-
opus using the various mCAR 5P-£anking sequences to drive
Fig. 4. Transient transfection analysis of the mCAR promoter^lucif-
erase constructs in Weri-Rb-1 and COS-7 cells. The three di¡erent
5P-£anking fragments (p-215, p-523 and p-1003) in the pRL-null
vector were transfected into either COS-7 or Weri-Rb-1 retinoblas-
toma cells with or without CRX co-transfection. The cells were pro-
cessed and assayed for luciferase activity 44 h after transfection.
The promoterless pRL-null vector was used as a control for basal
luciferase activity of the cells and its luciferase activity was set at 1.
Values are means+S.E.M. of results from three independent experi-
ments performed in duplicate.
Fig. 5. mCAR upstream sequences direct cone-speci¢c expression of
EGFP in transgenic Xenopus tadpoles. A: Bright ¢eld and £uores-
cent lighting conditions showing EGFP expression in the eye, pineal
and other tissues of the tadpole. B: EGFP expression in the eye. C:
Fluorescent image of a radial cross-section of the retina of a trans-
genic tadpole generated using the pmCAR523-EGFP showing
EGFP expression in the cone photoreceptors. D: Image of the same
section under bright ¢eld and £uorescent lighting conditions show-
ing EGFP expression limited to the cone photoreceptors. Arrows
identify cone photoreceptor cells expressing high levels of EGFP.
RPE, retinal pigment epithelium; PR, photoreceptors.
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an enhanced GFP (EGFP) reporter gene. Expression from the
longest construct (p-1003) was weak in all tadpoles and was
detectable in the eye, forebrain, heart and at lower levels
throughout the nervous system (data not shown). Expression
from the shorter promoter constructs (p-523 and p-215) was
signi¢cantly higher, and readily detected early in development,
by stage 42. These data con¢rm the promoter activity ana-
lyzed in Weri-Rb-1 retinoblastoma cells. In transgenic tad-
poles harboring either of the two shorter constructs, promi-
nent expression was seen in the eye, pineal gland, heart,
individual nerve ¢bers in the jaw and head, and at lower levels
throughout the nervous system (Fig. 5A). The non-speci¢c
expression in tissues other than retina and pineal has been
noticed in other laboratories with other retina-speci¢c pro-
moters from species other than Xenopus to drive reporter ex-
pression in Xenopus retina. However, the reason for this non-
speci¢c expression is unclear (personal communications with
other researchers at ARVO and with Dr. Barry E. Knox).
In frozen sections of tadpole eyes, EGFP expression was
observed prominently in cone photoreceptors, identi¢ed by
the colorless oil droplet in the myoid region (Fig. 5C,D).
The EGFP expression was seen in the abundant cone photo-
receptors throughout the retina, but it was not possible to
distinguish cone subtypes in these animals. No EGFP expres-
sion was observed in other cell types of the retina. These
experiments demonstrate that the proximal promoter of the
mCAR gene is capable of driving cone-speci¢c expression in
the retina. Within this region, the TATA box, Sp1 site and
two CRX-binding sites are highly conserved between the
mCAR and the hCAR genes. However, the Ret-1 site in the
proximal hCAR promoter is replaced by a CRX-binding site
in the mCAR gene, and the most distal CRX-binding site and
the PCE1-like element in the hCAR gene are absent in the
mCAR gene (Fig. 3) [33]. Comparison of the mCAR gene
5P-£anking region with that of the red, green and blue opsin
genes and the cone transducin K subunit gene [59] did not
reveal any highly conserved regions except the TATA box
region (data not shown), consistent with the hCAR gene. It
is noteworthy that all cone-speci¢c genes have a typical
TATA box in their proximal promoter regions, but most of
the rod-speci¢c genes lack the TATA box. It is thus possible
that the combination of a TATA box with CRX-binding ele-
ments is necessary for cone-speci¢c expression. However, we
cannot exclude the possibility that unidenti¢ed cis-elements
within the proximal promoter region of the CAR gene might
also contribute to its cone-speci¢c expression. Further dele-
tion and mutagenesis studies of the 215-bp 5P-£anking region
of mCAR are being directed to elucidate such cone-speci¢c
elements.
Taken together, we have characterized the gene structure,
multiple transcripts, and the 5P-£anking region of mCAR to
facilitate further functional study using a CAR knockout
mouse model. Using the new technology of examining pro-
moter activity with EGFP reporter in transgenic Xenopus, we
have also demonstrated that a 215-bp fragment containing the
proximal promoter region of mCAR is su⁄cient to drive cone
photoreceptor- and pineal-enriched expression, providing a
useful molecular tool for targeting expression in cone photo-
receptors and pinealocytes.
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